New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness

Authors:

Abstract
OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella catarrhalis are under development. However, the potential health benefits and economic effects of such candidate vaccines have not been systematically assessed.

This publication has 41 references indexed in Scilit: